{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:35:31Z","timestamp":1789929331915,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.tiv.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,5,21]],"date-time":"2017-05-21T10:17:12Z","timestamp":1495361832000},"page":"374-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"P3","title":["Comparison and validation of an in vitro skin sensitization strategy using a data set of 33 chemical references"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8812-2229","authenticated-orcid":false,"given":"Elodie","family":"Clouet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadia","family":"Kerdine-R\u00f6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jacques","family":"Ferret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2017.05.014_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15476910600978038","article-title":"Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis","volume":"3","author":"Ade","year":"2006","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00204-011-0693-2","article-title":"Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010","volume":"85","author":"Adler","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.tiv.2010.07.005","article-title":"Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program","volume":"24","author":"Aeby","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tiv.2015.09.028","article-title":"Prospective multicentre study of the U-SENS test method for skin sensitization testing","volume":"30","author":"Al\u00e9p\u00e9e","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.tiv.2005.10.012","article-title":"Development of an in vitro skin sensitization test using human cell lines: the human cell line activation test (h-CLAT). I. Optimization of the h-CLAT protocol","volume":"20","author":"Ashikaga","year":"2006","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/026119291003800403","article-title":"A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA)","volume":"38","author":"Ashikaga","year":"2010","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.tiv.2017.05.014_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.0105-1873.2005.00490.x","article-title":"Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation","volume":"52","author":"Basketter","year":"2005","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tiv.2017.05.014_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DER.0000000000000003","article-title":"Categorization of chemicals according to their relative human skin sensitizing potency","volume":"25","author":"Basketter","year":"2014","journal-title":"Dermat."},{"key":"10.1016\/j.tiv.2017.05.014_bb0045","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.tiv.2011.05.030","article-title":"Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals","volume":"25","author":"Bauch","year":"2011","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.yrtph.2012.05.013","article-title":"Putting the parts together: combining in vitro methods to test for skin sensitizing potentials","volume":"63","author":"Bauch","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0055","doi-asserted-by":"crossref","DOI":"10.1542\/peds.105.1.e3","article-title":"Does sensitization to contact allergens begin in infancy?","volume":"105","author":"Bruckner","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.tiv.2017.05.014_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1979.10","article-title":"Describing the validity of carcinogen screening tests","volume":"39","author":"Cooper","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tiv.2017.05.014_bb0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.tiv.2015.02.012","article-title":"Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay","volume":"29","author":"Cottrez","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0075","series-title":"In Vitro Skin Sensitization Analysis of Mixtures: Results Using the SENS-IS Assay","author":"Cottrez","year":"2016"},{"key":"10.1016\/j.tiv.2017.05.014_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tiv.2016.01.007","article-title":"SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: reproducibility and predictivity results from an inter-laboratory study","volume":"32","author":"Cottrez","year":"2016","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jat.1758","article-title":"Inter-relationships between different classes of chemical allergens","volume":"33","author":"Dearman","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0090","series-title":"Validation and Regulatory Acceptance of Alternative Methods and Approaches","article-title":"EURL ECVAM status report on the development","author":"EURL-ECVAM","year":"2016"},{"key":"10.1016\/j.tiv.2017.05.014_bb0095","series-title":"Chapter R7a: Endpoint Specific Guidance","article-title":"Guidance on information requirements and chemical safety assessment","author":"European Chemicals Agency","year":"2016"},{"key":"10.1016\/j.tiv.2017.05.014_bb0100","series-title":"EURL ECVAM Recommendation on the Human Cell Line Activation Test (h-CLAT) for Skin Sensitisation Testing","author":"European Commission","year":"2015"},{"key":"10.1016\/j.tiv.2017.05.014_bb0105","article-title":"Consolidated version of the REACH Regulation. Commission Regulation (EU) 2016\/1688 of 20 September 2016 Amending Annex VII to Regulation (EC) No 1907\/2006 of the European Parliament and of the Council on the Registration","author":"European Parliament","year":"2016"},{"key":"10.1016\/j.tiv.2017.05.014_bb0110","article-title":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes","volume":"33\u201379","author":"European Union","year":"2010","journal-title":"Off. J. Eur. Union"},{"key":"10.1016\/j.tiv.2017.05.014_bb0115","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00204-016-1842-4","article-title":"State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies","volume":"90","author":"Ezendam","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.vascn.2014.06.001","article-title":"Development of a prediction method for skin sensitization using novel cysteine and lysine derivatives","volume":"70","author":"Fujita","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tiv.2017.05.014_bb0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/kfh213","article-title":"Development of a peptide reactivity assay for screening contact allergens","volume":"81","author":"Gerberick","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.05.014_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfm064","article-title":"Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach","volume":"97","author":"Gerberick","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.05.014_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/026119290803600210","article-title":"Chemical reactivity measurement and the predictive identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64","volume":"36","author":"Gerberick","year":"2008","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.tiv.2017.05.014_bb0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/toxsci\/kfp192","article-title":"Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system","volume":"112","author":"Gerberick","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.05.014_bb0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.yrtph.2003.07.001","article-title":"Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data","volume":"38","author":"Griem","year":"2003","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0150","article-title":"The murine Local Lymph Node Assay: a test method for assessing the allergic contact dermatitis for potential of chemicals\/compounds","author":"ICCVAM","year":"1999"},{"key":"10.1016\/j.tiv.2017.05.014_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/jat.2869","article-title":"Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice","author":"Jaworska","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0160","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00204-015-1634-2","article-title":"Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative Weight of Evidence and adaptive testing strategy","volume":"89","author":"Jaworska","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0190-9622(83)80070-X","article-title":"Allergic contact dermatitis to simple chemicals: a molecular approach","volume":"8","author":"Jordan","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/tx7002239","article-title":"Allergic contact dermatitis\u2014formation, structural requirements, and reactivity of skin sensitizers","volume":"21","author":"Karlberg","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/1046-199X(95)90068-3","article-title":"Contact and respiratory sensitization by chemical allergens: uneasy relationships","volume":"6","author":"Kimber","year":"1995","journal-title":"Am. J. Contact Dermat."},{"key":"10.1016\/j.tiv.2017.05.014_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0278-6915(92)90153-C","article-title":"The murine local lymph node assay: a commentary on collaborative studies and new directions","volume":"30","author":"Kimber","year":"1992","journal-title":"Food Chem. Toxicol."},{"issue":"Suppl","key":"10.1016\/j.tiv.2017.05.014_bb0185","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1093\/toxsci\/kfq346","article-title":"Chemical allergy: translating biology into hazard characterization","volume":"120","author":"Kimber","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.05.014_bb0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.64.4.625","article-title":"Studies on the sensitization of animals with simple chemical compounds. II","volume":"64","author":"Landsteiner","year":"1936","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tiv.2017.05.014_bb0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-483X(95)03279-O","article-title":"Further evaluation of the local lymph node assay in the final phase of an international collaborative trial","volume":"108","author":"Loveless","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2017.05.014_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.14573\/altex.2013.4.473","article-title":"From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment","volume":"30","author":"MacKay","year":"2013","journal-title":"ALTEX"},{"key":"10.1016\/j.tiv.2017.05.014_bb0205","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1398-9995.2011.02652.x","article-title":"Mechanisms of chemical-induced innate immunity in allergic contact dermatitis","volume":"66","author":"Martin","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.tiv.2017.05.014_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15569527.2010.483869","article-title":"A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE\/EpRE-mediated gene expression in human skin cells","volume":"29","author":"McKim","year":"2010","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/15569527.2012.667031","article-title":"An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing","volume":"31","author":"McKim","year":"2012","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/toxsci\/kfm259","article-title":"Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals","volume":"102","author":"Natsch","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.05.014_bb0225","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jat.2868","article-title":"A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation","volume":"33","author":"Natsch","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/toxsci\/kfu229","article-title":"Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment","volume":"143","author":"Natsch","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.05.014_bb0235","series-title":"Clinical Immunotoxicology","author":"Newcombe","year":"1992"},{"key":"10.1016\/j.tiv.2017.05.014_bb0240","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2017.05.014_bb0245","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tiv.2012.11.006","article-title":"Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals","volume":"27","author":"Nukada","year":"2013","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0250","series-title":"Test No. 406: Skin Sensitisation, Guideline for Testing of Chemicals","author":"OECD","year":"1992"},{"key":"10.1016\/j.tiv.2017.05.014_bb0255","series-title":"Test No. 429: Skin Sensitisation: Local Lymph Node Assay, Guideline for Testing of Chemicals","author":"OECD","year":"2010"},{"key":"10.1016\/j.tiv.2017.05.014_bb0260","series-title":"Test No. 442A: Skin Sensitization: Local Lymph Node Assay: DA","author":"OECD","year":"2010"},{"key":"10.1016\/j.tiv.2017.05.014_bb0265","series-title":"Test No. 442B: Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA","author":"OECD","year":"2010"},{"key":"10.1016\/j.tiv.2017.05.014_bb0270","series-title":"Scientific Evidence OECD Environment, Health and Safety Publications Series on Testing and Assessment","article-title":"The adverse outcome pathway for skin sensitisation initiated by covalent binding for proteins. Part 1","author":"OECD","year":"2012"},{"key":"10.1016\/j.tiv.2017.05.014_bb0275","series-title":"Test No. 442C: In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA)","author":"OECD","year":"2015"},{"key":"10.1016\/j.tiv.2017.05.014_bb0280","series-title":"Test No. 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method","author":"OECD","year":"2015"},{"key":"10.1016\/j.tiv.2017.05.014_bb0285","series-title":"ENV\/JM\/MONO(2016)28","article-title":"Guidance document on the reporting of defined approaches to be used within integrated approaches to testing and assessment","author":"OECD","year":"2016"},{"key":"10.1016\/j.tiv.2017.05.014_bb0290","series-title":"ENV\/JM\/MONO(2016)29","article-title":"Guidance document on the reporting of defined approaches and individual information sources to be used within integrated approaches to testing and assessment (IATA) for skin sensitization","author":"OECD","year":"2016"},{"key":"10.1016\/j.tiv.2017.05.014_bb0295","series-title":"Test No. 442E: In Vitro Skin Sensitisation: Human Cell Line Activation Test (h-CLAT)","author":"OECD","year":"2016"},{"key":"10.1016\/j.tiv.2017.05.014_bb0300","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yrtph.2014.06.001","article-title":"Towards AOP application\u2014implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization","volume":"69","author":"Patlewicz","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0305","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.tiv.2015.03.009","article-title":"The myeloid U937 skin sensitization test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization","volume":"29","author":"Piroird","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0310","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.tiv.2014.08.002","article-title":"LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification","volume":"28","author":"Ramirez","year":"2014","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0315","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tiv.2016.01.004","article-title":"Intra- and inter-laboratory reproducibility and accuracy of the LuSens assay: a reporter gene-cell line to detect keratinocyte activation by skin sensitizers","volume":"32","author":"Ramirez","year":"2016","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0320","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0536.1998.tb05944.x","article-title":"Fragrances and other materials in deodorants: search for potentially sensitizing molecules using combined GC-MS and structure activity relationship (SAR) analysis","volume":"39","author":"Rastogi","year":"1998","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tiv.2017.05.014_bb0325","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tiv.2014.10.018","article-title":"Systematic evaluation of non-animal test methods for skin sensitisation safety assessment","volume":"29","author":"Reisinger","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0330","series-title":"The Principles of Humane Experimental Technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.tiv.2017.05.014_bb0335","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.taap.2007.03.006","article-title":"Dendritic cells and skin sensitization: biological roles and uses in hazard identification","volume":"221","author":"Ryan","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0340","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.tiv.2005.10.014","article-title":"Development of an in vitro skin sensitization test using human cell lines; human cell line activation test (h-CLAT). II. An inter-laboratory study of the h-CLAT","volume":"20","author":"Sakaguchi","year":"2006","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10565-008-9059-9","article-title":"The relationship between CD86\/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test - human cell line activation test (h-CLAT)","volume":"25","author":"Sakaguchi","year":"2009","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0350","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.tiv.2010.05.012","article-title":"Predicting skin sensitization potential and inter-laboratory reproducibility of a human cell line activation test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials","volume":"24","author":"Sakaguchi","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0355","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yrtph.2004.02.002","article-title":"Quantitative relationship between the local lymph node assay and human skin sensitization assays","volume":"39","author":"Schneider","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0360","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jat.3281","article-title":"Integrated decision strategies for skin sensitization hazard","volume":"36","author":"Strickland","year":"2016","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0536.2007.01220.x","article-title":"The epidemiology of contact allergy in the general population\u2014prevalence and main findings","volume":"57","author":"Thyssen","year":"2007","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tiv.2017.05.014_bb0370","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.yrtph.2014.09.009","article-title":"Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA)","volume":"70","author":"Tollefsen","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0375","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.tiv.2014.01.003","article-title":"Skin sensitization risk assessment model using artificial neural network analysis of data from multiple in vitro assays","volume":"28","author":"Tsujita-Inoue","year":"2014","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0380","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yrtph.2014.12.008","article-title":"Assessing skin sensitization hazard in mice and men using non-animal test methods","volume":"71","author":"Urbisch","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0385","doi-asserted-by":"crossref","unstructured":"van der Veen, J.., Vandebriel, R., van Loveren, H., Ezendam, J., 2011. Keratinocytes, Innate Immunity and Allergic Contact Dermatitis-Opportunities for the Development of In Vitro Assays to Predict the Sensitizing Potential of Chemicals. Ro YS, (Contact de. ed).","DOI":"10.5772\/28337"},{"key":"10.1016\/j.tiv.2017.05.014_bb0390","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tiv.2012.08.023","article-title":"Applicability of a keratinocyte gene signature to predict skin sensitizing potential","volume":"27","author":"van der Veen","year":"2013","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2017.05.014_bb0395","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.yrtph.2014.04.018","article-title":"Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals","volume":"69","author":"van der Veen","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0400","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/10408444.2014.925425","article-title":"Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: analysis of existing data","volume":"44","author":"van der Veen","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tiv.2017.05.014_bb0405","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00003-009-0510-5","article-title":"Safe cosmetics without animal testing? Contributions of the EU Project Sens-it-iv","volume":"4","author":"Weltzien","year":"2009","journal-title":"J. Verbr. Lebensm."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233317301303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233317301303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:30:33Z","timestamp":1760135433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233317301303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":80,"alternative-id":["S0887233317301303"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2017.05.014","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison and validation of an in vitro skin sensitization strategy using a data set of 33 chemical references","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}